Recombinant EGFR (Matuzumab Biosimilar) antibody

Catalog No. ABIN7487799

The Mammalian Cells Monoclonal anti-EGFR (Matuzumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect EGFR (Matuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant EGFR (Matuzumab Biosimilar) antibody (ABIN7487799)

Target: EGFR (Matuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This EGFR (Matuzumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-EGFR (Matuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Matuzumab Biosimilar - Anti-EGFR mAb

Characteristics: Antibody Type: IgG1-nd

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for EGFR (Matuzumab Biosimilar)

Target: EGFR (Matuzumab Biosimilar)

Target Type: Biosimilar

Background: EMD-72000,H425,h425
Matuzumab (formerly EMD 72000) is a humanized monoclonal antibody for the treatment of cancer. It binds to the epidermal growth factor receptor (EGFR) with high affinity.

CAS-No: 339186-68-4